BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mago R, Tripathi N, Andrade C. Cardiovascular adverse effects of newer antidepressants. Expert Review of Neurotherapeutics 2014;14:539-51. [DOI: 10.1586/14737175.2014.908709] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
Number Citing Articles
1 Richter T, Alusik S, Paluch Z, Burianova I, Cybulja A, Sadilkova L. Suppressive effect of citalopram on plasma concentrations of thromboxane B 2. Scandinavian Journal of Clinical and Laboratory Investigation 2015;75:615-20. [DOI: 10.3109/00365513.2015.1066848] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Joshi S, Tepper SJ, Lucas S, Rasmussen S, Nelson R. A narrative review of the importance of pharmacokinetics and drug-drug interactions of preventive therapies in migraine management. Headache 2021;61:838-53. [PMID: 34214182 DOI: 10.1111/head.14135] [Reference Citation Analysis]
3 Wu S, Zhou Y, Xuan Z, Xiong L, Ge X, Ye J, Liu Y, Yuan L, Xu Y, Ding G, Xiao A, Guo J, Yu L. Repeated use of SSRIs potentially associated with an increase on serum CK and CK-MB in patients with major depressive disorder: a retrospective study. Sci Rep 2021;11:13365. [PMID: 34183728 DOI: 10.1038/s41598-021-92807-7] [Reference Citation Analysis]
4 Kahl KG, Westhoff-bleck M, Krüger TH. Effects of psychopharmacological treatment with antidepressants on the vascular system. Vascular Pharmacology 2017;96-98:11-8. [DOI: 10.1016/j.vph.2017.07.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
5 Chang C, Tzeng N, Yeh C, Kuo TBJ, Huang S, Chang H. Effects of depression and melatonergic antidepressant treatment alone and in combination with sedative–hypnotics on heart rate variability: Implications for cardiovascular risk. The World Journal of Biological Psychiatry 2018;19:368-78. [DOI: 10.1080/15622975.2017.1294765] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
6 Baumann P, Bertschy G, Ramseier F, Nil R. Plasma Concentrations and Cardiovascular Effects of Citalopram Enantiomers After Oral Versus Infusion Citalopram Therapy in Dextromethorphan-Mephenytoin-Phenotyped Patients With Major Depression. Ther Drug Monit 2021;43:436-42. [PMID: 33060488 DOI: 10.1097/FTD.0000000000000824] [Reference Citation Analysis]
7 Almog R, Carasso S, Lavi I, Amir O. The risk for a first acute coronary syndrome in patients treated with different types of antidepressants: A population based nested case-control study. International Journal of Cardiology 2018;267:28-34. [DOI: 10.1016/j.ijcard.2018.04.137] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
8 Mareti E, Ampatzi C, Paschou SA, Voziki E, Goulis DG. Non-Hormonal Replacement Therapy Regimens: Do they have an Effect on Cardiovascular Risk? Curr Vasc Pharmacol 2019;17:573-8. [PMID: 30205798 DOI: 10.2174/1570161116666180911104942] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Kahl KG. Direct and indirect effects of psychopharmacological treatment on the cardiovascular system. Horm Mol Biol Clin Investig 2018;36. [PMID: 30427780 DOI: 10.1515/hmbci-2018-0054] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
10 Correll CU, Detraux J, De Lepeleire J, De Hert M. Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder. World Psychiatry 2015;14:119-36. [PMID: 26043321 DOI: 10.1002/wps.20204] [Cited by in Crossref: 366] [Cited by in F6Publishing: 328] [Article Influence: 61.0] [Reference Citation Analysis]
11 Veríssimo LF, Volpini VL, Estrada VB, Matsubara NK, Gomes MV, Resstel LBM, Correa FMA, Pelosi GG. Treatment with escitalopram modulates cardiovascular function in rats. Eur J Pharmacol 2018;824:120-7. [PMID: 29428469 DOI: 10.1016/j.ejphar.2018.02.003] [Reference Citation Analysis]
12 Mizutani H, Sakakibara F, Komuro M, Sasaki E. TAS-303, a Novel Selective Norepinephrine Reuptake Inhibitor that Increases Urethral Pressure in Rats, Indicating Its Potential as a Therapeutic Agent for Stress Urinary Incontinence. J Pharmacol Exp Ther 2018;366:322-31. [PMID: 29875227 DOI: 10.1124/jpet.118.248039] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
13 Buoli M, Grassi S, Serati M, Altamura AC. Agomelatine for the treatment of generalized anxiety disorder. Expert Opinion on Pharmacotherapy 2017;18:1373-9. [DOI: 10.1080/14656566.2017.1359257] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
14 Wang SM, Han C, Bahk WM, Lee SJ, Patkar AA, Masand PS, Pae CU. Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review. Chonnam Med J 2018;54:101-12. [PMID: 29854675 DOI: 10.4068/cmj.2018.54.2.101] [Cited by in Crossref: 54] [Cited by in F6Publishing: 40] [Article Influence: 18.0] [Reference Citation Analysis]
15 Yeh T, Kao L, Tzeng N, Kuo TB, Huang S, Chang C, Chang H. Heart rate variability in major depressive disorder and after antidepressant treatment with agomelatine and paroxetine: Findings from the Taiwan Study of Depression and Anxiety (TAISDA). Progress in Neuro-Psychopharmacology and Biological Psychiatry 2016;64:60-7. [DOI: 10.1016/j.pnpbp.2015.07.007] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 6.2] [Reference Citation Analysis]
16 Martin H, Bullich S, Guiard BP, Fioramonti X. The impact of insulin on the serotonergic system and consequences on diabetes-associated mood disorders. J Neuroendocrinol 2021;33:e12928. [PMID: 33506507 DOI: 10.1111/jne.12928] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
17 Sheikh MA. Leisure time physical activity and incident use of prescription tranquilizers: A longitudinal population-based study. Journal of Affective Disorders 2018;238:327-35. [DOI: 10.1016/j.jad.2018.06.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Paolucci S. Advances in antidepressants for treating post-stroke depression. Expert Opin Pharmacother 2017;18:1011-7. [PMID: 28535081 DOI: 10.1080/14656566.2017.1334765] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 9.8] [Reference Citation Analysis]